
Stephan Grupp MD PhD
@gruppsteve
#CARTCell expert, bone marrow transplanter, pediatric oncologist, husband to my vastly better half. All opinions my own, not an investor. RT not=endorsementđđ
ID: 2241533694
https://www.chop.edu/centers-programs/cancer-immunotherapy-program 11-12-2013 23:58:56
3,3K Tweet
4,4K Followers
658 Following

We need to work together to get the therapies that people with #sicklecelldisease need! Today we meet at the The White House to discuss #genetherapy so we can get #SCD transformed!! #WhiteHouseCGT



Amazing The Philadelphia Orchestra concert tonight with Yannick Nezet-Seguin and Yuja Wang doing the Tchaikovsky Piano Concerto #1. Wonderful performance and Wang encore. Played the crowdâs standing ovation as well as the Concerto.


Our Cell Therapy and Transplant group at Cancer Center @ CHOP always looks forward to the annual Alex's Lemonade Stand Foundation Lemon Ball. Always an amazing event, always so great to hear from the heroes and from Liz and Jay Scott. Caroline Diorio Regina Myers



Large long term CAR T safety data: -426 adults and 357 kids -tiny risk of 2nd cancers overall and lower in kids -lineage switch isn't a 2nd primary malignancy -many pts with long-term CAR persistence -many children in long term response/persistence category Cancer Center @ CHOP

Our Center recently celebrated its 600th patient treated with CAR T-cell immunotherapy, a groundbreaking âliving drugâ that utilizes the patientâs immune system to fight cancer. Pioneered at CHOP and Penn Medicine, CAR T has transformed cancer treatment worldwide.



Why isnât PA on the list of states suing to reverse this policy? Josh Shapiro Eugene DePasquale U.S. Senator John Fetterman U Penn Cancer Center @ CHOP CHOP Research


In this Journal of Clinical Oncology editorial, the author discusses two studies by CHOP's Dr. Ted Laetsch, emphasizing importance of precision medicine treatments that target specific genetic makeup of cancers, promising improved outcomes and reduced toxicity for patients: ms.spr.ly/6017qnfgJ.



Congratulation to the 2025 class of Fellows of the AACR Academy including Stand Up To Cancer community members Dr. Nina Bhardwaj Icahn School of Medicine at Mount Sinai, Stephan Grupp MD PhD Penn Medicine - Abramson Cancer Center, Ari Melnick Weill Cornell Medicine, William Sellers Broad Institute and Robert Vonderheide Penn Medicine - Abramson Cancer Center!!

New #JITC article: CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy bit.ly/3EDIVJu Marco Ruella @gruppsteve Regina Myers Caroline Diorio


